Objectives TYK2 is a common genetic risk factor for several autoimmune diseases. This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc). Therefore, we aimed to assess the possible role of this locus in SSc. Methods This study comprised a total of 7103 patients with SSc and 12â €..220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK. Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus. Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression. Meta-Analyses were performed using the inverse variance method. Results Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis (p=3.08×10 â '13, OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals (p=2.28×10 â '3, OR=0.80; p=1.27×10 â '3, OR=0.59; p=2.63×10 â '5, OR=0.83, respectively). Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants. Conclusions We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology.

Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway / E. Lopez-Isac, D. Campillo-Davo, L. Bossini-Castillo, S.G. Guerra, S. Assassi, C.P. Simeon, P. Carreira, N. Ortego-Centeno, P. Garcia De La Pena, L. Beretta, A. Santaniello, C. Bellocchi, C. Lunardi, G. Moroncini, A. Gabrielli, G. Riemekasten, T. Witte, N. Hunzelmann, A. Kreuter, J.H. Distler, A.E. Voskuyl, J. De Vries-Bouwstra, A. Herrick, J. Worthington, C.P. Denton, C. Fonseca, T.R. Radstake, M.D. Mayes, J. Martin. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 75:8(2016), pp. 1521-1526. [10.1136/annrheumdis-2015-208154]

Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

A. Santaniello;C. Bellocchi;J. Martin
Ultimo
2016

Abstract

Objectives TYK2 is a common genetic risk factor for several autoimmune diseases. This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc). Therefore, we aimed to assess the possible role of this locus in SSc. Methods This study comprised a total of 7103 patients with SSc and 12â €..220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK. Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus. Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression. Meta-Analyses were performed using the inverse variance method. Results Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis (p=3.08×10 â '13, OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals (p=2.28×10 â '3, OR=0.80; p=1.27×10 â '3, OR=0.59; p=2.63×10 â '5, OR=0.83, respectively). Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants. Conclusions We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology.
Cytokines; Gene Polymorphism; Systemic Sclerosis; Treatment
Settore MED/09 - Medicina Interna
2016
2-set-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
nihms-1577813.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 415.99 kB
Formato Adobe PDF
415.99 kB Adobe PDF Visualizza/Apri
1521.full.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 902.84 kB
Formato Adobe PDF
902.84 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/957433
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 38
social impact